历史沿革 History
建于1958年（原日坛医院），是中国第一所肿瘤专科医院，也是国家癌症中心（National Cancer Center）所在地。
Founded in 1958, it is described as China's first specialized oncology hospital and serves as the National Cancer Center.
医院级别与规模 Grade & Scale
- 医院级别：三级甲等肿瘤专科医院。
Grade: Tertiary Grade-A Cancer Hospital. - 床位数：编制与开放床位约1,200-1,500余张（含廊坊/深圳等多院区）。
Beds: Approximately 1,200–1,500+ beds across multiple campuses (including Langfang and Shenzhen). - 诊疗与手术规模（年）：年门急诊量约100万人次，年出院/住院量约8万-10万人次，年肿瘤切除手术超过3万-4万例。
Annual Volume: ~1 million outpatient/emergency visits, ~80,000–100,000 inpatient admissions, and 30,000–40,000+ tumor resection surgeries annually.
检验与硬件设备 Equipment & Diagnostics
拥有质子重离子治疗系统、多台高精度Edge/TrueBeam直线加速器、PET-CT及3.0T肿瘤高分辨率MRI。
Equipped with Proton and Heavy Ion Therapy Systems, TrueBeam and Edge linear accelerators, PET-CT, and high-resolution 3.0T oncology MRI.
特色专科 Key Specialties
胸外科（食管癌/肺癌）、胸部肿瘤内科、乳腺外科、腹部外科、肿瘤放射治疗科。
Thoracic Surgical Oncology (Esophageal/Lung Cancer), Thoracic Medical Oncology, Breast Surgery, Abdominal Surgical Oncology, and Radiation Oncology.
学术论文与引用 Publications & Citations
在Lancet Oncology、Cancer Cell、Journal of Clinical Oncology（JCO）等期刊发表大量文章，主导中国癌症登记与生存率数据发布。
Frequently publishes in Lancet Oncology, Cancer Cell, and Journal of Clinical Oncology (JCO); responsible for releasing China's official cancer registry and survival-rate data.
国际合作 Global Partnerships
与美国纪念斯隆凯特琳癌症中心（MSKCC）、MD Anderson癌症中心等机构有肿瘤临床科研合作。
Maintains clinical and research partnerships with Memorial Sloan Kettering Cancer Center (MSKCC) and MD Anderson Cancer Center